Journey Medical Corp reports results for the quarter ended in December - Earnings Summary

Journey Medical

29/03/2023 22:02

* Journey Medical Corp  DERM.OQ  reported a quarterly
adjusted
loss of 60 cents​​ per share for the quarter ended in December.
The mean expectation of three analysts for the quarter was for a
loss of 47 cents per share.
    * Revenue fell 8.9% to $15.97 million from a year ago;
analysts
expected $16.58 million. 
    * Journey Medical Corp's reported EPS for the quarter was a
loss
of 60 cents​.
    * The mean earnings estimate of analysts was unchanged in
the last
three months.​ 
    * In the last 30 days, there have been no earnings estimate
revisions by analysts covering the company. 
    * Journey Medical Corp shares had fallen by 28.6% this
quarter.
    * The company reported a quarterly loss of $10.64 million.
    * Wall Street's median 12-month price target for Journey
Medical
Corp is $6.00 
    * The current average analyst rating on the shares is "buy"
and
the breakdown of recommendations is 3 "strong buy" or "buy," no
"hold" and no "sell" or "strong sell." 

This summary was machine generated from LSEG Refinitiv data
March 29 at 09:02 p.m. UTC. ​All figures in US dollars unless
otherwise stated. QUARTER ENDING    ESTIMATE       ACTUAL         BEAT, MET,
                                                 MISSED
 Dec. 31 2022      -0.47          -0.60          Missed
 Sep. 30 2022      -0.40          -0.57          Missed
 Jun. 30 2022      -0.26          -0.43          Missed
 Mar. 31 2022      -0.31          -0.08          Beat